Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK9027 (GR agonist 23a) is a nonsteroidal glucocorticoid receptor (GR) agonist.GSK9027 is a partial agonist on the 2×GRE reporter gene compared to dexamethasone and is less active than dexamethasone activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 128.00 | |
10 mg | In stock | $ 213.00 | |
25 mg | In stock | $ 447.00 | |
50 mg | In stock | $ 646.00 | |
100 mg | In stock | $ 888.00 | |
500 mg | In stock | $ 1,790.00 |
Description | GSK9027 (GR agonist 23a) is a nonsteroidal glucocorticoid receptor (GR) agonist.GSK9027 is a partial agonist on the 2×GRE reporter gene compared to dexamethasone and is less active than dexamethasone activity. |
Synonyms | GR agonist 23a, GSK 9027, GSK-9027 |
Molecular Weight | 525.52 |
Formula | C27H19F4N3O2S |
CAS No. | 1229096-88-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (38.06 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK9027 1229096-88-1 Endocrinology/Hormones Glucocorticoid Receptor GR agonist 23a GSK 9027 GSK-9027 inhibitor inhibit